June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Visual acuity gain after cross linking (CXL) cases : role of cone excentration.
Author Affiliations & Notes
  • SOT Maxime
    OPHTALMOLOGY, CHR METZ-THIONVILLE, Nancy, France
  • Julie FRANCOIS
    OPHTALMOLOGY, CHR METZ-THIONVILLE, Nancy, France
  • Marie-Soline LUC
    OPHTALMOLOGY, CHR METZ-THIONVILLE, Nancy, France
  • François Tortuyaux
    OPHTALMOLOGY, CHR METZ-THIONVILLE, Nancy, France
  • YAHIA Rekia
    OPHTALMOLOGY, CHR METZ-THIONVILLE, Nancy, France
  • Charlotte JAUD
    OPHTALMOLOGY, CHR METZ-THIONVILLE, Nancy, France
  • Nadia ouamara
    OPHTALMOLOGY, CHR METZ-THIONVILLE, Nancy, France
  • Christophe Goetz
    OPHTALMOLOGY, CHR METZ-THIONVILLE, Nancy, France
  • Jean-Marc Perone
    OPHTALMOLOGY, CHR METZ-THIONVILLE, Nancy, France
  • Footnotes
    Commercial Relationships   SOT Maxime, None; Julie FRANCOIS, None; Marie-Soline LUC, None; François Tortuyaux, None; YAHIA Rekia, None; Charlotte JAUD, None; Nadia ouamara, None; Christophe Goetz, None; Jean-Marc Perone, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5676. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      SOT Maxime, Julie FRANCOIS, Marie-Soline LUC, François Tortuyaux, YAHIA Rekia, Charlotte JAUD, Nadia ouamara, Christophe Goetz, Jean-Marc Perone; Visual acuity gain after cross linking (CXL) cases : role of cone excentration.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5676.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Although it isn't the first aim of cross linking (CXL), it was reported that some patients have shown improved best corrected visual acuity (BCVA) after a cross linking procedure. The aim of this study is to evaluate the proportion of BCVA improvement after cross linking, and trying to find explanation to this phenomenon in analyzing cone excentration evolution.

Methods : All consecutive patients treated with CXL between march 2014 and May 2016 were included. They all underwent the same procedure: accelerated-CXL protocole (De-epithelialization, 30 minutes Riboflavin impregnation followed by 10 minutes UVA irradiation at 9 mW/cm2 intensity). Irradiation device : IROC UV-X™ 2000, Medeuronet. The indication of all these CXL was a progressive keratoconus. Patients were divided into two groups. First group was composed of patients with BVCA improvement after CXL. The second group consisted in patients whose BCVA remained steady or was lower after CXL procedure. Visual acuity was assessed before CXL, and 6 months after CXL. Cone excentration evolution,(defined as the difference between conus excentration before CXL and six months after CXL), using OCULUS Pentacam. These characteristics were compared using a Student test.

Results : 80 patients (90 eyes) who underwent CXL were included. Mean age was 26 (SD=10 )years. 33 % were female. 40 eyes were included in the first group, 50 eyes in the second group : 44,4 % of eyes who underwent CXL procedure had BVCA improvement. BCVA mean variation after CXL procedure was -0,22 logMar (SD=0,19) in the first group. BCVA mean variation after CXL procedure was 0,08 logMar (SD=0,12) in the second group. The cone excentration was decreased of 0,03mm (SD=0,22) in the first group. The cone excentration was decreased of 0,01mm (SD=0,38) in the second group. There was no significant difference in the two groups concerning conus excentration evolution (student test : p= 0,75).

Conclusions : Although some cases had a decreased excentration of the cone associated to a BCVA gain, our study did not show any difference of conus excentration variation between patients with BCVA improvement, compared to those whose BCVA remained stable or went lower. There might exist other factors that influence visual acuity gain after CXL procedure that still need to be found out.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×